ask="2.900"
ask_size="500"
average_daily_volume="6508"
bid="2.000"
bid_size="100"
book_value="0.383"
change="-0.009"
change_from_200_day_moving_average="0.184"
change_from_50_day_moving_average="0.010"
change_from_52_week_high="-0.219"
change_From_52_week_low="0.941"
change_in_percent="-0.443%"
close="2.021"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.209"
ebitda="-2.96M"
eps_estimate_current_year="N/A"
eps_estimate_next_quarter="0.000"
eps_estimate_next_year="N/A"
ex_dividend_date="N/A"
float_shares="10636000"
high="2.021"
high_52_weeks="2.240"
last_trade_date="1/5/2017"
last_trade_price="2.021"
last_trade_size="100"
last_trade_time="12:43pm"
low="2.021"
low_52_weeks="1.080"
market_capitalization="34.52M"
moving_average_200_day="1.837"
moving_average_50_day="2.011"
name="ProPhase Labs
Inc."
notes="N/A"
one_year_target_price="15.550"
open="2.021"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="+10.028%"
percent_change_from_50_day_moving_average="+0.487%"
percent_change_from_52_week_high="-9.777%"
percent_change_from_52_week_low="+87.130%"
previous_close="2.030"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="5.300"
price_per_sales="1.608"
revenue="21.57M"
shares_outstanding="17080000"
short_ratio="0.920"
stock_exchange="NCM"
symbol="PRPH"
volume="286"
weeks_range_52="1.080 - 2.240"
